Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Neylan

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The New England Journal of Medicine|January 31, 1991
The effect of race on access and outcome in transplantationB L Kasiske, J F Neylan, R R Riggio, et al.
Transplantation|September 27, 1995
Delayed urinary bladder leak after combined kidney-pancreas transplantation. Association with penile prosthesis implantationT C Pearson, A A Futral, K L Routenberg, et al.
Clinical Transplantation|June 1, 1997
Drainage of the exocrine pancreas in clinical transplantation: comparison of bladder versus enteric drainage in a consecutive seriesT C Pearson, P J Santamaria, K L Routenberg, et al.
Transplantation|February 27, 1994
The evaluation of candidates for renal transplantation. The current practice of U.S. transplant centersE L Ramos, B L Kasiske, S R Alexander, et al.
Journal of the American Society of Nephrology : JASN|October 3, 1999
The allocation of cadaver kidneys for transplantation in the United States: consensus and controversy. ASN Transplant Advisory Group. American Society of NephrologyJ F Neylan, M H Sayegh, T M Coffman, et al.
Lancet (London, England)|May 10, 1997
Microchimerism and rejection in clinical transplantationE T Elwood, C P Larsen, D H Maurer, et al.
Clinical Transplants|January 1, 1996
Evolving strategies in immunosuppressive therapy: the Emory experienceJ D Whelchel, L C Hymes, E L Hochgelerent, et al.
Annals of Internal Medicine|July 1, 1995
Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trialP L Hibberd, N E Tolkoff-Rubin, D Conti, et al.
Clinical Transplants|January 1, 1993
Racial issues in renal transplantation: the Emory University experienceJ D Whelchel, J F Neylan, E D Frederickson, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 29, 2001
Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxisR H Rubin, S A Kemmerly, D Conti, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The New England Journal of Medicine|January 31, 1991
The effect of race on access and outcome in transplantationB L Kasiske, J F Neylan, R R Riggio, et al.
Transplantation|September 27, 1995
Delayed urinary bladder leak after combined kidney-pancreas transplantation. Association with penile prosthesis implantationT C Pearson, A A Futral, K L Routenberg, et al.
Clinical Transplantation|June 1, 1997
Drainage of the exocrine pancreas in clinical transplantation: comparison of bladder versus enteric drainage in a consecutive seriesT C Pearson, P J Santamaria, K L Routenberg, et al.
Transplantation|February 27, 1994
The evaluation of candidates for renal transplantation. The current practice of U.S. transplant centersE L Ramos, B L Kasiske, S R Alexander, et al.
Journal of the American Society of Nephrology : JASN|October 3, 1999
The allocation of cadaver kidneys for transplantation in the United States: consensus and controversy. ASN Transplant Advisory Group. American Society of NephrologyJ F Neylan, M H Sayegh, T M Coffman, et al.
Lancet (London, England)|May 10, 1997
Microchimerism and rejection in clinical transplantationE T Elwood, C P Larsen, D H Maurer, et al.
Clinical Transplants|January 1, 1996
Evolving strategies in immunosuppressive therapy: the Emory experienceJ D Whelchel, L C Hymes, E L Hochgelerent, et al.
Annals of Internal Medicine|July 1, 1995
Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trialP L Hibberd, N E Tolkoff-Rubin, D Conti, et al.
Clinical Transplants|January 1, 1993
Racial issues in renal transplantation: the Emory University experienceJ D Whelchel, J F Neylan, E D Frederickson, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 29, 2001
Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxisR H Rubin, S A Kemmerly, D Conti, et al.
Pageof 4